Patient Information: Breast Cancer Risk –Reducing Medications

This JAMA Patient Page describes the indications for use of medications to reduce breast cancer risk and the benefits and risks of the 2 major drug classes, SERMs (tamoxifen, raloxifene) and aromatase inhibitors (anastrozole, exemestane).

https://jamanetwork.com/journals/jama/fullarticle/2768467

Source: JAMA - July 21, 2020 Category: General Medicine Source Type: research